IRONWOOD PHARMACEUTICALS, INC. Shares Outstanding (Cover Page)
IRONWOOD PHARMACEUTICALS, INC. (IRWD) had Shares Outstanding (Cover Page) of 165.24 million shares as of 2026-07-31, per its 10-Q filed 2026-08-06.
Financial Statements › Notes › Cover Page
dei:EntityCommonStockSharesOutstanding · last filed 2026-08-06
- 2026-07-31: Entity Common Stock, Shares Outstanding 165.24M shares.
- 2026-04-30: Entity Common Stock, Shares Outstanding 164.61M shares.
- 2026-01-31: Entity Common Stock, Shares Outstanding 163.06M shares.
- 2025-10-31: Entity Common Stock, Shares Outstanding 162.68M shares.
| Period end | Entity Common Stock, Shares Outstanding |
|---|---|
| 2026-07-31 | 165.24M shares 10-Q · filed 2026-08-06 |
| 2026-04-30 | 164.61M shares 10-Q · filed 2026-05-07 |
| 2026-01-31 | 163.06M shares 10-K · filed 2026-02-26 |
| 2025-10-31 | 162.68M shares 10-Q · filed 2025-11-10 |
| 2025-07-31 | 162.43M shares 10-Q · filed 2025-08-11 |
| 2025-04-30 | 161.82M shares 10-Q · filed 2025-05-12 |
| 2025-02-28 | 161.81M shares 10-K · filed 2025-03-31 |
| 2024-10-31 | 160.03M shares 10-Q · filed 2024-11-07 |
| 2024-07-31 | 159.74M shares 10-Q · filed 2024-08-08 |
| 2024-04-30 | 158.96M shares 10-Q · filed 2024-05-09 |
| 2024-01-31 | 156.53M shares 10-K · filed 2024-02-16 |
| 2023-10-31 | 156.13M shares 10-Q · filed 2023-11-09 |
| 2023-07-31 | 156.03M shares 10-Q · filed 2023-08-09 |
| 2023-04-30 | 155.35M shares 10-Q · filed 2023-05-04 |
| 2023-01-31 | 154.16M shares 10-K · filed 2023-02-16 |
| 2022-10-31 | 153.40M shares 10-Q · filed 2022-11-03 |
| 2022-07-31 | 153.23M shares 10-Q · filed 2022-08-04 |
| 2022-04-30 | 153.84M shares 10-Q · filed 2022-05-05 |
| 2022-01-31 | 159.22M shares 10-K · filed 2022-02-18 |
| 2021-10-31 | 163.65M shares 10-Q · filed 2021-11-04 |
| 2021-07-31 | 162.90M shares 10-Q · filed 2021-08-05 |
| 2021-04-30 | 161.97M shares 10-Q · filed 2021-05-06 |
| 2021-02-10 | 160.96M shares 10-K · filed 2021-02-17 |
| 2020-11-02 | 160.10M shares 10-Q · filed 2020-11-05 |
| 2020-08-03 | 159.98M shares 10-Q · filed 2020-08-06 |
| 2020-05-01 | 159.38M shares 10-Q · filed 2020-05-06 |
| 2020-02-10 | 158.21M shares 10-K · filed 2020-02-13 |
| 2019-10-25 | 156.82M shares 10-Q · filed 2019-10-31 |
| 2019-07-26 | 156.50M shares 10-Q · filed 2019-07-30 |
| 2019-04-30 | 155.62M shares 10-Q · filed 2019-05-02 |
| 2019-02-12 | 154.65M shares 10-K · filed 2019-02-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Nuvectis Pharma, Inc. (NVCT) | United States | $0.705B | -17.53 |
| Climb Bio, Inc. (CLYM) | United States | $0.683B | -13.03 |
| Verastem, Inc. (VSTM) | United States | $0.706B | -1.71 |
| ZEVRA THERAPEUTICS, INC. (ZVRA) | United States | $0.668B | 14.61 |
| COLLEGIUM PHARMACEUTICAL, INC (COLL) | United States | $0.737B | 24.57 |
| BlossomHill Therapeutics, Inc. (BLSM) | United States | $0.647B | |
| Faeth Therapeutics, Inc. (FTH) | United States | $0.750B | |
| Shattuck Labs, Inc. (STTK) | United States | $0.634B | -13.30 |
| Neurogene Inc. (NGNE) | $0.625B | -4.46 | |
| Design Therapeutics, Inc. (DSGN) | United States | $0.766B | -12.78 |